Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 19:3:e1428.
doi: 10.7717/peerj.1428. eCollection 2015.

Lipopolysaccharide induces a downregulation of adiponectin receptors in-vitro and in-vivo

Affiliations

Lipopolysaccharide induces a downregulation of adiponectin receptors in-vitro and in-vivo

Alison Hall et al. PeerJ. .

Abstract

Background. Adipose tissue contributes to the inflammatory response through production of cytokines, recruitment of macrophages and modulation of the adiponectin system. Previous studies have identified a down-regulation of adiponectin in pathologies characterised by acute (sepsis and endotoxaemia) and chronic inflammation (obesity and type-II diabetes mellitus). In this study, we investigated the hypothesis that LPS would reduce adiponectin receptor expression in a murine model of endotoxaemia and in adipoocyte and myocyte cell cultures. Methods. 25 mg/kg LPS was injected intra-peritoneally into C57BL/6J mice, equivalent volumes of normal saline were used in control animals. Mice were killed at 4 or 24 h post injection and tissues harvested. Murine adipocytes (3T3-L1) and myocytes (C2C12) were grown in standard culture, treated with LPS (0.1 µg/ml-10 µg/ml) and harvested at 4 and 24 h. RNA was extracted and qPCR was conducted according to standard protocols and relative expression was calculated. Results. After LPS treatment there was a significant reduction after 4 h in gene expression of adipo R1 in muscle and peri-renal fat and of adipo R2 in liver, peri-renal fat and abdominal wall subcutaneous fat. After 24 h, significant reductions were limited to muscle. Cell culture extracts showed varied changes with reduction in adiponectin and adipo R2 gene expression only in adipocytes. Conclusions. LPS reduced adiponectin receptor gene expression in several tissues including adipocytes. This reflects a down-regulation of this anti-inflammatory and insulin-sensitising pathway in response to LPS. The trend towards base line after 24 h in tissue depots may reflect counter-regulatory mechanisms. Adiponectin receptor regulation differs in the tissues investigated.

Keywords: Adiponectin; Adiponectin receptors; Adipose tissue; Lipopolysaccharide.

PubMed Disclaimer

Conflict of interest statement

The authors declare there are no competing interests.

Figures

Figure 1
Figure 1. Adiponectin receptor gene expression in 3T3-L1 adipocytes 4 h following LPS challenge.
Relative change adiponectin receptor gene expression in mouse adipocyte cell line (3T3-L1) incubated for 4 h (n = 6 run in duplicate) with varying concentrations of LPS. Gene expression was determined by real-time PCR. Relative gene expression was calculated using the 2-ddCt method and p < 0.05 was considered significant. Error bars correspond to Standard Error of Mean (p < 0.05, ∗∗p < 0.01). Housekeeping gene was β-actin. (R1, AdipoR1; R2, AdipoR2).
Figure 2
Figure 2. Adiponectin receptor gene expression in 3T3-L1 adipocytes 24 following LPS challenge.
Relative change adiponectin receptor gene expression in mouse adipocyte cell line (3T3-L1) incubated for 24 h (n = 6 run in duplicate) with varying concentrations of LPS. Gene expression was determined by real-time PCR. Relative gene expression was calculated using the 2-ddCt method and p < 0.05 was considered significant. Error bars correspond to Standard Error of Mean (p < 0.05, ∗∗p < 0.01). Housekeeping gene was β-actin. (R1, AdipoR1; R2, AdipoR2).
Figure 3
Figure 3. Adiponectin receptor expression in C2C12 myocytes 4 h following LPS challenge.
Relative change adiponectin receptor gene expression in mouse isolated myocytes (C2C12) incubated for 4 h (n = 6 run in duplicate) with varying concentrations of LPS. Gene expression was determined by real-time PCR. Relative gene expression was calculated using the 2-ddCt method and p < 0.05 was considered significant. Error bars correspond to Standard Error of Mean (p < 0.05, ∗∗p < 0.01). Housekeeping gene was β-actin. (R1, AdipoR1; R2, AdipoR2).
Figure 4
Figure 4. Adiponectin receptor expression in C2C12 myocytes 24 h following LPS challenge.
Relative change adiponectin receptor gene expression in mouse isolated myocytes (C2C12) incubated for 24 h (n = 6 run in duplicate) with varying concentrations of LPS. Gene expression was determined by real-time PCR. Relative gene expression was calculated using the 2-ddCt method and p < 0.05 was considered significant. Error bars correspond to Standard Error of Mean (p < 0.05, ∗∗p < 0.01). Housekeeping gene was β-actin. (R1, AdipoR1; R2, AdipoR2).
Figure 5
Figure 5. Adiponectin gene expression in 3T3-L1 adipocytes 4 h following LPS challenge.
Relative change adiponectin receptor gene expression in mouse adipocyte cell line (3T3-L1) incubated for 4 h (n = 6 run in duplicate) varying concentrations of LPS. Gene expression was determined by real-time PCR. Relative gene expression was calculated using the 2-ddCt method and p < 0.05 was considered significant. Error bars correspond to Standard Error of Mean (p < 0.05, ∗∗p < 0.01). Housekeeping gene was β-actin. (R1, AdipoR1; R2, AdipoR2).
Figure 6
Figure 6. Adiponectin gene expression in 3T3-L1 adipocytes 24 h following LPS challenge.
Relative change adiponectin receptor gene expression in mouse adipocyte cell line (3T3-L1) incubated for 24 h (n = 6 run in duplicate) varying concentrations of LPS. Gene expression was determined by real-time PCR. Relative gene expression was calculated using the 2-ddCt method and p < 0.05 was considered significant. Error bars correspond to Standard Error of Mean (p < 0.05, ∗∗p < 0.01). Housekeeping gene was β-actin. (R1, AdipoR1; R2, AdipoR2).

References

    1. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. Insulin resistance and substrate utilization in human endotoxemia. Journal of Clinical Endocrinology and Metabolism. 2000;85:3770–3778. doi: 10.1210/jcem.85.10.6914. - DOI - PubMed
    1. Ajuwon KM, Banz W, Winters TA. Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes. Journal of Inflammation. 2009;6 doi: 10.1186/1476-9255-6-8. Article 8. - DOI - PMC - PubMed
    1. Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP. Innate immunity modulates adipokines in humans. Journal of Clinical Endocrinology and Metabolism. 2007;92:2272–2279. doi: 10.1210/jc.2006-2545. - DOI - PubMed
    1. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, Richey JM, Ader M. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. American Journal of Medicine. 2007;120:S3–S8. doi: 10.1016/j.amjmed.2006.11.012. - DOI - PubMed
    1. Bjursell M, Ahnmark A, Bohlooly YM, William-Olsson L, Rhedin M, Peng XR, Ploj K, Gerdin AK, Arnerup G, Elmgren A, Berg AL, Oscarsson J, Linden D. Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes. 2007;56:583–593. doi: 10.2337/db06-1432. - DOI - PubMed

LinkOut - more resources